Hopp til innhold

Hjerte- og karkirurgi

Antikoagulasjonsbehandling og reversering

Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. (åpner nytt vindu)

Chai-Adisaksopha C, Hillis C, Siegal DM, Movilla R, Heddle N, Iorio A, Crowther M.

Kilde‎: Thromb Haemost 2016;116(5):879-90.

Arkiv‎: PubMed 27488143

DOI‎: 10.1160/TH16-04-0266

https://www.ncbi.nlm.nih.gov/pubmed/27488143 (åpner nytt vindu)

Reversal of warfarin: case-based practice recommendations. (åpner nytt vindu)

Garcia DA, Crowther MA.

Kilde‎: Circulation 2012;125(23):2944-7.

Arkiv‎: PubMed 22689931

DOI‎: 10.1161/CIRCULATIONAHA.111.081489

https://www.ncbi.nlm.nih.gov/pubmed/22689931 (åpner nytt vindu)

Stopping antiplatelet medication before coronary artery bypass graft surgery: is there an optimal timing to minimize bleeding? (åpner nytt vindu)

Gielen CL, Bruggemans EF, Stijnen T, Eikenboom J, Tavilla G, Brand A, Klautz RJ.

Kilde‎: Eur J Cardiothorac Surg 2015;48(4):e64-70.

Arkiv‎: PubMed 26248820

DOI‎: 10.1093/ejcts/ezv269

https://www.ncbi.nlm.nih.gov/pubmed/26248820 (åpner nytt vindu)

Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit? (åpner nytt vindu)

Mahmood S, Bilal H, Zaman M, Tang A.

Kilde‎: Interact Cardiovasc Thorac Surg 2012;14(4):406-14.

Arkiv‎: PubMed 22228288

DOI‎: 10.1093/icvts/ivr124

https://www.ncbi.nlm.nih.gov/pubmed/22228288 (åpner nytt vindu)

Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes. (åpner nytt vindu)

Mangoush O, Purkayastha S, Haj-Yahia S, Kinross J, Hayward M, Bartolozzi F, Darzi A, Athanasiou T.

Kilde‎: Eur J Cardiothorac Surg 2007;31(6):1058-69.

Arkiv‎: PubMed 17306555

DOI‎: 10.1016/j.ejcts.2007.01.029

https://www.ncbi.nlm.nih.gov/pubmed/17306555 (åpner nytt vindu)

Heparin-coated extracorporeal circulation in combination with low dose systemic heparinization reduces early postoperative blood loss in cardiac surgery. (åpner nytt vindu)

Mirow N, Zittermann A, Koertke H, Maleszka A, Knobl H, Coskun T, Kleesiek K, Koerfer R.

Kilde‎: J Cardiovasc Surg (Torino) 2008;49(2):277-84.

Arkiv‎: PubMed 18431350

https://www.ncbi.nlm.nih.gov/pubmed/18431350 (åpner nytt vindu)

Idarucizumab for dabigatran reversal. (åpner nytt vindu)

Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI.

Kilde‎: N Engl J Med 2015;373(6):511-20.

Arkiv‎: PubMed 26095746

DOI‎: 10.1056/NEJMoa1502000

https://www.ncbi.nlm.nih.gov/pubmed/26095746 (åpner nytt vindu)

Idarucizumab for dabigatran reversal - full cohort analysis. (åpner nytt vindu)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Kilde‎: N Engl J Med 2017;377(5):431-41.

Arkiv‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (åpner nytt vindu)

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. (åpner nytt vindu)

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

Kilde‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

Arkiv‎: PubMed 18068065

DOI‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 (åpner nytt vindu)

Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. (åpner nytt vindu)

Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN.

Kilde‎: Circulation 2013;128(11):1234-43.

Arkiv‎: PubMed 23935011

DOI‎: 10.1161/CIRCULATIONAHA.113.002283

https://www.ncbi.nlm.nih.gov/pubmed/23935011 (åpner nytt vindu)

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. (åpner nytt vindu)

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

Kilde‎: JAMA Surg 2013;148(6):538-47.

Arkiv‎: PubMed 23426385

DOI‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 (åpner nytt vindu)

Andexanet alfa for the reversal of Factor Xa inhibitor activity. (åpner nytt vindu)

Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, Mathur VS, Castillo J, Bronson MD, Leeds JM, Mar FA, Gold A, Crowther MA.

Kilde‎: N Engl J Med 2015;373(25):2413-24.

Arkiv‎: PubMed 26559317

DOI‎: 10.1056/NEJMoa1510991

https://www.ncbi.nlm.nih.gov/pubmed/26559317 (åpner nytt vindu)

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. (åpner nytt vindu)

Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW.

Kilde‎: Blood 2012;119(9):2172-4.

Arkiv‎: PubMed 22383791

DOI‎: 10.1182/blood-2011-11-393587

https://www.ncbi.nlm.nih.gov/pubmed/22383791 (åpner nytt vindu)

Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting. (åpner nytt vindu)

Øvrum E, Tangen G, Tølløfsrud S, Skeie B, Ringdal MA, Istad R, Øystese R.

Kilde‎: J Thorac Cardiovasc Surg 2011;141(5):1145-9.

Arkiv‎: PubMed 20709334

DOI‎: 10.1016/j.jtcvs.2010.07.003

https://www.ncbi.nlm.nih.gov/pubmed/20709334 (åpner nytt vindu)